http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-102015005853-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87d1f15f71536ff61cdb08b7cca50302 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea8a50ce663fa031bb37f513a9357621 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 |
| filingDate | 2015-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_daeccd53cf1bb018d1c05d5779ed70ff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_885f2a15bbc1aba683055147a69ab5f4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94ec64d20c9021004bd667269e5181dc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71e666572595e0bf06f0cd71abf37f95 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ae892f429913847922e8711c9589091 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7318ef8810ce2a8aad85e4430d841ca2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7649af4b7375a373fda7de25c940e2aa |
| publicationDate | 2016-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-102015005853-A2 |
| titleOfInvention | peptide, use of peptide, vaccine, kit, pharmaceutical composition, and method for treating disorders related to antigen presentation by mhc-i |
| abstract | peptide, use of the peptide, vaccine, kit, pharmaceutical composition, and method for treating disorders related to antigen presentation by mhc-i. The present invention is in the field of immunology. The present invention relates to peptide el28 conjugated or not to cationic peptide derived from tat protein (region 47-57). The present invention further relates to the use of said protease-activating peptide as a vaccine adjuvant for the manufacture of a medicament for treating disorders related to proliferation of t cds + cells related to mhc-i antigen presentation and to production of a medicine for activating proteasomes. The present invention further relates to the vaccine comprising said peptide as an adjuvant. The present invention further relates to a kit for treating disorders related to antigen presentation by mhc-i. The present invention further relates to the pharmaceutical composition. The present invention further relates to a method for treating disorders related to antigen presentation by mhc-i. |
| priorityDate | 2015-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 318.